From One Expert’s Eye to Objective Data
Two radiologists can look at the same scan and walk away with two different reads — and that gap can shape what happens to a patient next. Quantitative imaging biomarkers (QIBs) close that gap by turning what’s seen into what’s measured.
- A QIB is a measurable physical or biological trait pulled directly from a medical image.
- QIBs can flag healthy biological activity, point to disease, or show how a patient is responding to treatment.
- With today’s processing power, extracting biomarkers adds little to no extra cost to everyday radiology workflows.
- Our medical image analysis software turns these readings into validated, reproducible clinical metrics.
3 Applications of Quantitative Imaging Biomarkers in Healthcare
QIBs aren’t a single technique — they’re a way of reading images that unlocks three distinct kinds of clinical value.
Connecting medical images to biological events
- Reveals what’s actually happening inside the body.
- Sharpens diagnosis and treatment plans.
- Shows whether therapy is working.
- Catches conditions like NASH early and grades them accurately.
- Combines T1, T2, and diffusion-weighted MRI for layered prognostics.
Supporting precision medicine and bedside decisions
- Covers entire regions or the whole body, not just a tissue slice.
- Tracks changes over time without repeated invasive procedures.
- Fills the gaps that lab-based markers leave behind.
- Improves therapy development and treatment monitoring.
- Realistic for everyday radiology workflows.
Rethinking medical imaging technology
- Most modalities are nearing physical limits of spatial resolution.
- The next frontier is meaning, not just clarity.
- QIBs turn pixels into physiological insight.
- Bridges what’s visible and what’s causing it.
- Shifts the goal from prettiest picture to most useful insight.
Quantitative Imaging Biomarkers Across Modalities
Modern imaging gives us such a detailed look at the body that QIBs can be drawn from nearly every modality — each one offering a distinct window into structure, function, or biology.
CT scans
Strong spatial detail makes CT well-suited for tissue characterization, tumor sizing, perfusion and necrosis readings, angiographic insights, and dynamic contrast studies.
MRI signals
Once properly calibrated, MRI signals translate cleanly into biomarkers that describe tissue structure and function — from fat content to fibrosis and beyond.
PET imaging
Highly sensitive, with radiotracers that can profile a wide range of molecular and physiological activity — ideal for oncology, neurology, and cardiology biomarkers.
Ultrasound
Opens up reflection, attenuation, refraction, bulk tissue traits, shear wave speed, distance, elasticity, and Doppler flow measurements — non-invasively and at low cost.
X-ray and digital radiography
Supports quantitative reads on bone density, joint spacing, and structural changes over time — the workhorse of musculoskeletal and chest QIBs.
Nuclear medicine scans
SPECT and related modalities add functional uptake data that complements anatomical scans — revealing how organs and tissues are actually performing.
Optical and hybrid modalities
Optical coherence tomography, photoacoustic imaging, and hybrid PET/MR systems are widening the QIB toolkit further as imaging hardware keeps evolving.
Multi-sequence MRI for NASH
T1 and T2 sequences map fat deposits while diffusion-weighted scans with intravoxel incoherent motion modeling capture inflammation — together forming a layered prognostic biomarker.
Functional MRI
Maps brain activity beautifully — tying that map back to underlying chemistry and electrical signals is the next puzzle QIBs are starting to solve.
Ali Amin
Healthcare IT Consultant & Doctor of Medicine
at INNERLUXES
“The hardest part of QIB validation isn’t the math — it’s the consistency. We design test protocols that hold up across vendors, scanners, and time points, with phantom calibration, repeatability studies, and bias checks built into every release. That’s how a biomarker earns clinical trust.
Selected Healthcare Imaging Projects by InnerLuxes
2 Models of Imaging Biomarkers
There are two main families of imaging biomarkers — and most clinical applications draw on one, the other, or both together.
Focuses on what tissue looks like — volume, shape, layout, and texture patterns drawn from co-occurrence matrices. Cortical thickness studies and lung emphysema readings are common examples.
Goes a layer deeper, measuring physical, chemical, and biological signals — like fat and iron content in the pancreas. These markers come out of dynamic modeling applied to the raw imaging data.
Most powerful diagnostic insights come from combining static and dynamic biomarkers — structure plus function in one read.
Challenges of Implementing QIBs — and How QIBA Solves Them
QIBs hold real promise, but rolling them out is genuinely complicated. Here’s what makes it hard — and how the field is closing the gap.
Complex multi-step development
Each QIB moves through careful stages — picking the target trait, choosing source images, locking in the analytical method, and deciding how to measure it.
High validation bar
Before clinical use, every QIB must clear conceptual soundness, technical repeatability, real accuracy, and clear clinical relevance — no shortcuts allowed.
Multi-stakeholder coordination
Imaging vendors, software makers, regulators, providers, and research bodies all have to align — that takes patience and structure.
Constantly evolving hardware
Imaging hardware and software keep moving forward. Every advance means rechecking accuracy and updating the standards that hold everything together.
QIBA Profiles as the playbook
The Quantitative Imaging Biomarkers Alliance publishes detailed Profiles — intended use, acquisition protocol, compliance checkpoints, and validation steps for every biomarker.
Reduced variability across devices
QIBA’s aim is straightforward — cut down the variability between devices, patients, and time points so biomarkers actually become useful in practice.
Standardized acquisition protocols
QIBA Profiles spell out the image acquisition protocol the biomarker relies on — so a scan in Tokyo reads the same as a scan in Toronto.
Clear roles and responsibilities
Each Profile spells out who does what — vendors, pharma teams, technologists, physicians, regulators — eliminating ambiguity in the pipeline.
Reporting and documentation
Consistent reporting formats and documentation expectations make biomarker outputs interpretable across institutions and over time.
Audience-shaped Profiles
Each Profile is tailored for the audience that needs it — device makers, pharma teams, researchers, physicians, regulators, and accreditation groups.
Technologies We Use for Medical Image Analysis
We pair proven imaging classics with modern AI — choosing the right toolset for your biomarker pipeline, not the trendiest one.
Front-end programming languages
HTML5
CSS3
JavaScript
Angular
React
Meteor
Vue.js
Next.js
EmberBack-end programming languages
.NET
Java
Python
Node.js
PHP
GoMobile
iOS
Android
Xamarin
Cordova
PWA
React Native
Flutter
IonicLow-code development
Power Apps
Power Automate
App Engine Studio
BubbleDatabases / Data Storages
SQL Server
MS Fabric
MySQL
Azure SQL
Oracle
PostgreSQL
Cassandra
Hive
HBase
NiFi
MongoDBBig Data
Hadoop
Spark
Kafka
ZooKeeper
Redshift
DynamoDB
DocumentDB
ElastiCache
Cosmos DB
Azure Blob
Data Lake
GC Datastore
InfluxDBCloud Databases, Warehouses & Storage
Amazon S3
Amazon RDS
Synapse Analytics
Cloud SQLPlatforms
Dynamics 365
Salesforce
Magento
SharePoint
ServiceNow
Power BI
SAPDevOps
Docker
Kubernetes
OpenShift
Mesos
Ansible
Puppet
Chef
SaltStack
Terraform
Packer
AWS Dev Tools
Azure DevOps
Google Dev Tools
Cisco
Jenkins
TeamCity
Zabbix
Nagios
Elasticsearch
Prometheus
Grafana
DatadogIoT
IoT Core
FreeRTOS
IoT Analytics
IoT Events
Greengrass
SiteWise
Device Mgmt
IoT Defender
Kinect DK
Notification Hubs
SQL Edge
Azure RTOS
IoT Central
Digital TwinsThe road to full QIB adoption
The way medical imaging is heading is good news for QIBs — but full clinical integration still needs an aligned ecosystem to take shape.
Current hurdles
- Mixed-up terminology across the field
- Inconsistent methods around technical performance
- Variability between devices, scanners, and vendors
- Infrastructure gaps in clinical settings
- Slow alignment among stakeholders
- Hardware advances outpacing standards
What needs to align
- Standardized acquisition protocols
- Agreed-upon display methods
- Shared analysis guidelines
- Consistent reporting formats
- Clear precision medicine pathways
- Faster diagnosis workflows in clinics and labs
Choose Your Service Option
Imaging consulting
You have a clinical question and need a path forward. Our consultants help you scope the right biomarker, modality, and validation strategy — before any code is written.
I’m Interested →QIB pipeline
development *
Hand your project — or part of it — to a team of 132+ professionals who’ve delivered 68 products across 30+ industries. We build the pipeline. You own it.
I’m Interested →Validation, modernization
and support
Your existing imaging system needs validation, a refresh, or reliable day-to-day care. We handle QIBA-aligned validation, full revamps, and ongoing maintenance.
I’m Interested →* To reduce time to validation, INNERLUXES recommends starting with a Proof-of-Concept biomarker pipeline. We can deliver your PoC in under 4 months and grow it iteratively into a fully validated, QIBA-aligned solution.
Quantitative Imaging Biomarkers – Q&A
A quantitative imaging biomarker is a measurable physical or biological trait pulled directly from a medical image. These markers can flag healthy biological activity, point to disease, or show how a patient is responding to treatment.
Specimen biomarkers usually come from a biopsy or fluid sample, giving you only a tiny slice of tissue. Imaging scans cover entire regions or the whole body, providing a fuller picture, and let you track changes over time without another invasive procedure.
QIBs can be drawn from nearly every modality — CT scans, MRI, PET imaging, ultrasound, X-ray and digital radiography, nuclear medicine scans like SPECT, and emerging optical and hybrid modalities.
The static anatomical model focuses on what tissue looks like — volume, shape, layout, and texture. The dynamic biological model measures physical, chemical, and biological signals through dynamic modeling applied to raw imaging data.
The Quantitative Imaging Biomarkers Alliance, formed by the Radiological Society of North America, works to make biomarkers more useful and practical by reducing variability between devices, patients, and time points through standardized QIBA Profiles.